2nd amendment to the 20F.

New Post Public Reply Private Reply Replies (1) Message Board
sevenOdouble
2nd amendment to the 20F.
http://www.sec.gov/Archives/edgar/data/143742...fr12ga.htm

New paragraphs are:
""The Company has designed POET to be relatively easy to implement utilizing industry standard tools and infrastructure. The ability to utilize industry standard circuit design tools and process flows enables low adoption cost for the implementation of POET. The POET wafer fabrication process is similar to that for current industry standard silicon CMOS, as POET supports current manufacturing and testing infrastructures, including test-on-wafer techniques, as well as post-fabrication procedures comparable to existing silicon CMOS procedures. The primary additional requirement for silicon CMOS foundries would involve the acquisition of molecular beam epitaxy (“MBE”) capability for the pre-processed GaAs wafers, or outsourcing the purchase of such wafers.""

"The Company seeks to monetize its technology assets by a combination of (i) license revenues for specific vertical markets, with grants of exclusive rights for agreed upon timeframes; (ii) foundry non-recurring engineering (“NRE”) revenues for POET technology transfer and support to foundries adding POET capability to their product and services offerings; (iii) foundry design kit royalty revenues from sales by foundries of libraries and designs kits incorporating POET to device designers developing new chip offerings; and (iv) royalties from sales by integrated circuit manufacturers and OEMs of POET chips sold individually or incorporated into an electronic device. The Company is targeting initial revenues from NRE to begin within twelve months of the date of this Registration Statement. In support of its marketing efforts, the Company is developing working prototypes of certain devices — ring oscillator and high-speed vertical cavity laser — in order to display the capabilities of POET. The Company projects that such prototypes will be ready for display and testing by the end of 2014."

new wording to emphasize that PET is also important: ... "In addition, the POET technology encompasses the ability to incorporate positive and negative heterostructure field effect transistors (“HFETs”) on a single GaAs wafer, thus substantially broadening the capabilities of a GaAs semiconductor device, as well as positive and negative heterojunction bipolar transistors (“HBTs”) on a single GaAs wafer, allowing for much greater power efficiency and speed, as well as the incorporation of analog and digital circuits in a single chip design."

May 15 20F filing:

The Company expects that the First Phase of commercialization will generate non-recurring engineering revenue with partners, foundries or both with an initial prototype device anticipated to be available by Q4 2014 into Q1 2015

June 12 20F filing:

The Company expects that the First Phase of commercialization will generate non-recurring engineering revenue with OEMs, foundries or both with an initial prototype device anticipated to be available by the end of 2014.

POET Technologies Inc. (POET) Stock Research Links

POET Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 24

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 33

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 28

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 18

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 37

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 46

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 30

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Gene-Editing Therapy CS-121 Revolutionizes Hyperlipidemia Treatment

Updated Category News Views 232

Transformative Progress in Gene-Editing Therapies CorrectSequence Therapeutics Co., Ltd. is at the forefront of biotechnology innovation with its promising gene-editing therapy, CS-121, designed to tackle chylomicronemia and hypertriglyceridemia. This breakthrough comes as an exciting advancement in the medical field, particularly for patients suffering from severe lipid...

Continue Reading
Blue Ridge Partners Showcases Expertise at PEI Forum Europe

Updated Category News Views 211

Blue Ridge Partners Takes Center Stage at Key Forum Blue Ridge Partners, a leading global management consultancy, will serve as the Knowledge Partner for a significant upcoming event in the private equity sector. The firm is excited to announce its role in the 2025 PEI Operating Partners Forum Europe, taking place in May. Over a decade of collaboration as the Knowledge...

Continue Reading
Alger Russell Innovation Index Q4 2025 Rebalancing Insights

Updated Category News Views 81

Alger Russell Innovation Index Changes for Q4 2025 Fred Alger Management, LLC, a notable growth equity investment manager, has announced significant updates to the Alger Russell Innovation Index. This announcement concerns the quarterly rebalancing that will take place after the trading session concludes. These changes reflect the ever-evolving landscape of investment...

Continue Reading
Partners Value Split Corp. Announces Redemption of Shares

Updated Category News Views 205

Partners Value Split Corp. to Redeem Class AA Preferred Shares Recently, Partners Value Split Corp. (the “Company”) shared exciting news regarding its Class AA Preferred Shares, Series 9. This announcement indicates the Company’s intention to redeem all of its outstanding 5,996,800 Preferred Shares, Series 9 for cash, in accordance with the established terms....

Continue Reading
Pagos' MCP Server: The Future of Payment Data Access?

Updated Category News Views 160

Pagos unveiled a significant upgrade to its Model Context Protocol (MCP) Server on February 17, 2026. This expansion aims to revolutionize how merchants access and analyze their verified payments data directly via AI chat agents like ChatGPT and Claude. Traders in the fintech space are already sizing up this move, pondering whether it marks a genuine leap forward or just...

Continue Reading